329 related articles for article (PubMed ID: 36037786)
1. LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions.
Entezari M; Taheriazam A; Orouei S; Fallah S; Sanaei A; Hejazi ES; Kakavand A; Rezaei S; Heidari H; Behroozaghdam M; Daneshi S; Salimimoghadam S; Mirzaei S; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Oct; 154():113609. PubMed ID: 36037786
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SNHG7-miRNA-mRNA axes crosstalk with oncogenic signaling pathways in human cancers.
Malakoti F; Alemi F; Yeganeh SJ; Hosseini F; Shabestani N; Samemaleki S; Maleki M; Daneshvar SF; Montazer M; Yousefi B
Chem Biol Drug Des; 2023 May; 101(5):1151-1161. PubMed ID: 35993390
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of lncRNA-miRNA-mRNA networks during osteogenic differentiation of bone marrow mesenchymal stem cells.
Liu J; Yao Y; Huang J; Sun H; Pu Y; Tian M; Zheng M; He H; Li Z
BMC Genomics; 2022 Jun; 23(1):425. PubMed ID: 35672672
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling.
Entezari M; Ghanbarirad M; Taheriazam A; Sadrkhanloo M; Zabolian A; Goharrizi MASB; Hushmandi K; Aref AR; Ashrafizadeh M; Zarrabi A; Nabavi N; Rabiee N; Hashemi M; Samarghandian S
Biomed Pharmacother; 2022 Jun; 150():112963. PubMed ID: 35468579
[TBL] [Abstract][Full Text] [Related]
5. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma.
Wang JY; Yang Y; Ma Y; Wang F; Xue A; Zhu J; Yang H; Chen Q; Chen M; Ye L; Wu H; Zhang Q
Biomed Pharmacother; 2020 Jan; 121():109627. PubMed ID: 31810120
[TBL] [Abstract][Full Text] [Related]
6. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
Zhang J; Liu L; Li J; Le TD
Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
8. LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
Venkatesh J; Wasson MD; Brown JM; Fernando W; Marcato P
Cancer Lett; 2021 Jul; 509():81-88. PubMed ID: 33848519
[TBL] [Abstract][Full Text] [Related]
9. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis.
Ashrafizadeh M; Gholami MH; Mirzaei S; Zabolian A; Haddadi A; Farahani MV; Kashani SH; Hushmandi K; Najafi M; Zarrabi A; Ahn KS; Khan H
Life Sci; 2021 Apr; 270():119006. PubMed ID: 33421521
[TBL] [Abstract][Full Text] [Related]
10. Competitive Endogenous RNA (ceRNA) Regulation Network of lncRNA-miRNA-mRNA in Colorectal Carcinogenesis.
Liu J; Li H; Zheng B; Sun L; Yuan Y; Xing C
Dig Dis Sci; 2019 Jul; 64(7):1868-1877. PubMed ID: 30734239
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
13. Long Non-Coding RNA in Glioma: Target miRNA and Signaling Pathways.
Dang Y; Wei X; Xue L; Wen F; Gu J; Zheng H
Clin Lab; 2018 Jun; 64(6):887-894. PubMed ID: 29945317
[TBL] [Abstract][Full Text] [Related]
14. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract][Full Text] [Related]
15. LncRNA-miRNA interaction is involved in colorectal cancer pathogenesis by modulating diverse signaling pathways.
Alshahrani SH; Al-Hadeithi ZSM; Almalki SG; Malviya J; Hjazi A; Mustafa YF; Alawady AHR; Alsaalamy AH; Joshi SK; Alkhafaji AT
Pathol Res Pract; 2023 Nov; 251():154898. PubMed ID: 37924797
[TBL] [Abstract][Full Text] [Related]
16. LncRNAs with miRNAs in regulation of gastric, liver, and colorectal cancers: updates in recent years.
Tam C; Wong JH; Tsui SKW; Zuo T; Chan TF; Ng TB
Appl Microbiol Biotechnol; 2019 Jun; 103(12):4649-4677. PubMed ID: 31062053
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hepatocellular carcinoma by baculovirus-mediated expression of long non-coding RNA PTENP1 and MicroRNA regulation.
Chen CL; Tseng YW; Wu JC; Chen GY; Lin KC; Hwang SM; Hu YC
Biomaterials; 2015 Mar; 44():71-81. PubMed ID: 25617127
[TBL] [Abstract][Full Text] [Related]
18. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
19. Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention.
Mirzaei S; Paskeh MDA; Okina E; Gholami MH; Hushmandi K; Hashemi M; Kalu A; Zarrabi A; Nabavi N; Rabiee N; Sharifi E; Karimi-Maleh H; Ashrafizadeh M; Kumar AP; Wang Y
J Exp Clin Cancer Res; 2022 Jul; 41(1):214. PubMed ID: 35773731
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs as regulators of epithelial mesenchymal transition in breast cancer: A recent review.
El-Ashmawy NE; Khedr EG; Abo-Saif MA; Hamouda SM
Life Sci; 2024 Jan; 336():122339. PubMed ID: 38097110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
